Category Specific RSS

Categories: News

Iress shares tank following profit downgrade attributed to challenging economic environment

Amid rising interest rates to counter inflation, investors have been keeping their powder dry which has prompted share market data company Iress (ASX: IRE) to issue a profit downgrade as a result of reduced trading activity across the investor community.

Defined by the company as “challenging macro conditions”, Iress has also cited supplier expenses that were higher than expected which were attributable to worsening foreign exchange rates due to pricing being in US dollars.

The subsequent impact of these challenges for Iress is a downgrade in their NPAT guidance for the year ending 31 December 2022 (FY22) to be in the range of $54m – $58m. This is down on the previous issued range of $63m – $72m.

“Profit expectations for the second half of this year have been impacted primarily by delays in the timing of new client opportunities,” said Iress CEO, Andrew Walsh.

“In addition, some costs are higher than we previously expected, including US dollar priced technology and software. While external macro conditions are volatile, we are making good progress in executing on our long-term strategies to build a more profitable and efficient Iress.”

As a provider of share market software, the Iress portfolio of products includes trading software, financial advice, investment management, mortgages, superannuation and data intelligence. The software is utilised by more than 500,000 users globally.

All is not lost for Iress however, with the Company anticipating that reduced activity in their mortgages segment will be pushed from FY22 to FY23 when lending conditions improve.

IRE shares responded poorly to this profit downgrade to open trading at $8.50 per share, down 19% from their previous $10.52 close.

Alfred Chan

Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.

Recent Posts

Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US

Atomo Diagnostics (ASX:AT1) has secured a significant new order for its patented Pascal cassette, with…

1 week ago

June 2025 quarter CPI no roadblock to August RBA rate cut

The June 2025 quarter CPI data released today were cheered by mortgage holders and share…

3 weeks ago

Vection Secures $7.3M Defence Extension as AI Demand Strengthens

AI Gains Ground in Defence Sector As governments increase investment in defence technology, AI-powered tools…

3 weeks ago

Calix Secures $44.9m ARENA Grant to Build Green Iron Plant with ZESTY Technology

Calix Limited (ASX:CXL) has taken a significant leap forward in developing Australia’s low-emissions steel value…

3 weeks ago

Harris Technology boosts retail margins in FY25 through growth of refurbished tech

Online tech retailer Harris Technology (ASX: HT8) has delivered a strong lift in gross product…

4 weeks ago

Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S.

In a significant move set to reshape rapid diagnostics in the U.S., ASX-listed Lumos Diagnostics…

1 month ago